- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lantus (glargine)
Total 1023 results
-
HealthPartners InstituteTerminated
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
SanofiCompleted
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
LMC Diabetes & Endocrinology Ltd.CompletedDiabetes Mellitus, Type 2Canada
-
Johns Hopkins UniversityTerminatedHypoglycemia | Type 1 DiabetesUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
GeropharmCompletedClamp StudyRussian Federation
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Tamra DukatzSanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Emory UniversityBoston Medical Center; Rush University; University of DenverCompleted
-
SanofiCompleted
-
Emory UniversityNovo Nordisk A/SCompleted
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Terminated
-
SanofiCompleted
-
Chattanooga-Hamilton County Hospital AuthorityTerminatedDiabetes Mellitus, Type 1 | Diabetic KetoacidosisUnited States
-
SanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
Emory UniversityNovo Nordisk A/SCompletedType 2 DiabetesUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Buckinghamshire Healthcare NHS TrustNovo Nordisk A/SUnknownDiabetes Mellitus, Type 1United Kingdom
-
SanofiCompletedDiabetes MellitusUnited States
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
Northumbria UniversityNewcastle UniversityCompletedType 1 Diabetes MellitusUnited Kingdom
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
SanofiCompleted
-
John H. Stroger HospitalCompletedType 2 DiabetesUnited States
-
Vanderbilt University Medical CenterSanofiCompleted
-
Emory UniversityCompletedBenefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
AstraZenecaEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompleted
-
Emory UniversitySanofiCompletedType 2 Diabetes | Inpatient HyperglycemiaUnited States
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
Inova Health Care ServicesTerminated
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada